Neurocrine Biosciences, Inc. (BVMF:N1BI34)

Neurocrine Biosciences Ratios and Metrics

Market cap in millions BRL. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 18, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Cap	67,725	75,435	72,093	69,099	61,242	42,946
Market Cap Growth	4.65%	4.64%	4.33%	12.83%	42.60%	-9.81%
Enterprise Value	62,392	69,776	68,793	64,990	56,482	41,507
PE Ratio	25.69	30.37	41.49	53.34	76.56	92.58
Forward PE	15.33	15.87	18.15	21.34	22.53	24.55
PEG Ratio	-	0.75	0.31	0.65	0.66	0.37
PS Ratio	4.30	4.96	5.76	6.89	7.74	7.13
PB Ratio	3.78	4.36	5.24	5.83	6.75	5.88
P/TBV Ratio	1.08	4.47	5.47	5.96	6.92	6.07
P/FCF Ratio	16.42	18.96	24.35	35.96	35.70	34.67
P/OCF Ratio	15.71	18.14	22.79	33.35	33.96	31.51
EV/Sales Ratio	4.13	4.59	5.50	6.48	7.14	6.89
EV/EBITDA Ratio	16.22	20.23	21.67	44.94	40.17	68.89
EV/EBIT Ratio	18.55	21.21	22.69	48.75	42.69	76.21
EV/FCF Ratio	15.13	17.54	23.24	33.83	32.92	33.51
Debt / Equity Ratio	0.13	0.13	0.18	0.12	0.05	0.32
Debt / EBITDA Ratio	0.64	0.64	0.76	1.57	0.99	3.88
Debt / FCF Ratio	0.56	0.56	0.82	1.19	0.81	1.89
Net Debt / Equity Ratio	-0.33	-0.33	-0.24	-0.27	-0.42	-0.20
Net Debt / EBITDA Ratio	-1.64	-1.64	-1.04	-2.22	-2.74	-2.39
Net Debt / FCF Ratio	-1.42	-1.42	-1.11	-1.67	-2.25	-1.16
Asset Turnover	0.69	0.69	0.68	0.67	0.67	0.60
Inventory Turnover	0.82	0.82	0.71	1.08	0.71	0.49
Quick Ratio	2.92	2.92	3.06	2.25	2.49	3.65
Current Ratio	3.39	3.39	3.40	2.45	2.70	3.96
Return on Equity (ROE)	16.38%	16.38%	14.16%	12.68%	10.03%	7.17%
Return on Assets (ROA)	10.06%	10.06%	11.50%	6.71%	8.10%	4.76%
Return on Invested Capital (ROIC)	18.04%	18.04%	20.28%	13.46%	16.60%	9.53%
Return on Capital Employed (ROCE)	17.44%	17.44%	19.65%	11.33%	13.62%	6.07%
Earnings Yield	3.89%	3.29%	2.41%	1.87%	1.31%	1.08%
FCF Yield	6.09%	5.27%	4.11%	2.78%	2.80%	2.88%
Buyback Yield / Dilution	0.27%	0.27%	1.31%	-0.50%	-0.39%	-0.34%

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.